These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8754091)

  • 61. [Proxybarbital (Ipronal) in the pathogenetic treatment of irritable bowel syndrome].
    Knapik Z; Lubczyńska-Kowalska W; Paradowski L; Szczeklik-Selinger E
    Pol Tyg Lek; 1983 Sep; 38(36):1105-7. PubMed ID: 6144092
    [No Abstract]   [Full Text] [Related]  

  • 62. Verapamil in the treatment of irritable bowel syndrome.
    Byrne S
    J Clin Psychiatry; 1987 Sep; 48(9):388. PubMed ID: 3624216
    [No Abstract]   [Full Text] [Related]  

  • 63. Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?
    Shen B; Soffer EE
    Cleve Clin J Med; 2003 Jan; 70(1):64-5. PubMed ID: 12549728
    [No Abstract]   [Full Text] [Related]  

  • 64. [Randomized double-blind therapeutic trial of Statiflor and placebo].
    Rautureau J; Lanoue R
    Med Chir Dig; 1979; 8(1):97-100. PubMed ID: 381799
    [No Abstract]   [Full Text] [Related]  

  • 65. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment.
    Olden KW
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S3-7. PubMed ID: 12825862
    [No Abstract]   [Full Text] [Related]  

  • 66. Irritable bowel syndrome: new tools and insights for the primary care physician.
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S8-20. PubMed ID: 12825863
    [No Abstract]   [Full Text] [Related]  

  • 67. [The synthetic leu-enkephalin--dalargin--in the therapy of the irritable bowel syndrome and chronic noninfectious undefined colitis].
    Smishchuk IuO
    Lik Sprava; 1998 Jun; (4):93-6. PubMed ID: 9784715
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical trial of an intestinal medication of natural origin for treatment of functional colonic diseases with accelerated transit].
    Auboiron J; Bloy J; Douffet G; Ducrocq A; Ferdani C; Gendre C; Jouhanneaud A; Lecocq JL; Legrand C; Nahum A; Scherrer B; Xuereb C
    Med Chir Dig; 1979; 8(1):85-9. PubMed ID: 470484
    [No Abstract]   [Full Text] [Related]  

  • 69. [Symptomatic therapy of irritable bowel syndrome. Which drug for which symptoms?].
    Madisch A; Hotz J
    MMW Fortschr Med; 2001 Sep; 143(39):28-30. PubMed ID: 11680924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Evaluation of economic aspects of diagnostic procedures in irritable bowel syndrome].
    Szymański Z; Depczyńska A; Jaroszewicz-Heigelmann H; Wierzbicka-Paczos E
    Wiad Lek; 1987 Feb; 40(3):163-6. PubMed ID: 3617733
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of irritable bowel syndrome with a calcium antagonist (pinaverium bromide): experience with 40 cases].
    Soriano C; Espejo H; García L
    Rev Gastroenterol Peru; 1992; 12(1):36-8. PubMed ID: 1457772
    [No Abstract]   [Full Text] [Related]  

  • 72. Eziopitant. Pfizer.
    Evangelista S
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1441-3. PubMed ID: 11890362
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Return of alosetron.
    Hyman PE; Garvey TQ
    Expert Opin Drug Saf; 2002 May; 1(1):1-4. PubMed ID: 12904154
    [No Abstract]   [Full Text] [Related]  

  • 74. [A multicenter controlled trial of a combination of kaolin, sterculia gum, meprobamate, and magnesium salts, in the irritable bowel syndrome (author's transl)].
    Capron JP; Zeitoun P; Julien D
    Gastroenterol Clin Biol; 1981 Jan; 5(1):67-72. PubMed ID: 7009302
    [No Abstract]   [Full Text] [Related]  

  • 75. [Use of hypothalamic phospholipid liposomes in patients with irritable bowel syndrome].
    Aguglia E; Di Cataldo A; Sapienza S; Urbano D; Latteri F
    Clin Ter; 1985 May; 113(3):205-9. PubMed ID: 4017499
    [No Abstract]   [Full Text] [Related]  

  • 76. [Comparative study of Kaologeais and Smectite in the treatment of colopathies].
    Dietsch R; Bonneville B
    Med Chir Dig; 1981; 10(6):549-51. PubMed ID: 7311645
    [No Abstract]   [Full Text] [Related]  

  • 77. [Comparison of the therapeutic effect of tranquilizers and amitriptyline in irritable colon].
    Zizka V; Trykarová J; Kozická O; Madzarovová-Nohejlová J
    Cesk Psychiatr; 1985 Apr; 81(2):100-2. PubMed ID: 2861912
    [No Abstract]   [Full Text] [Related]  

  • 78. [Action of prifinium bromide on the irritable colon].
    Meduri B; Albano O
    Minerva Dietol Gastroenterol; 1981; 27(1):17-9. PubMed ID: 6114463
    [No Abstract]   [Full Text] [Related]  

  • 79. Trimebutine, a new antispasmodic in the treatment of dyspepsia.
    Walters JM; Crean P; McCarthy CF
    Ir Med J; 1980 Oct; 73(10):380-1. PubMed ID: 7429788
    [No Abstract]   [Full Text] [Related]  

  • 80. FDA draws patients into alosetron risk management.
    Miller JL
    Am J Health Syst Pharm; 2000 Oct; 57(19):1736. PubMed ID: 11030021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.